Wyeth-Ayerst Laboratories c/o American Home Products

Registered Principal Details

Business Or Interest:
Pharmaceutical research, manufacturing and marketing.

Lobbying Interests:
Areas that effect pharmaceutical sales, marketing and availability in the state.

CEO Name:
Bernard Poussot
Assistant Vice President, State Government Affairs

Contact
RNW
Richard N Winget
150 Radnor-Chester Road
St. Davids, PA 19087
(610) 902-7603
(610) 964-5947
ebartz@stateandfed.com
www.wyeth.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 357
Assembly Bill 357
relating to: advertising for prescription drugs.

Bill Text and History

Against
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 467
Assembly Bill 467
relating to: gifts given or offered by prescription drug manufacturers and distributors to encourage practitioners to prescribe certain drugs and providing a penalty.

Bill Text and History

Against
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 499
Assembly Bill 499
relating to: human cloning and parthenogenesis and providing penalties.

Bill Text and History

None
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 606
Assembly Bill 606
relating to: an income and franchise tax credit for sales and use taxes paid on the purchase of electricity used in agricultural biotechnology and on the purchase of products used on livestock.

Bill Text and History

For
Notification Date
10/25/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 764
Assembly Bill 764
relating to: awards to persons suffering damages as the result of medical malpractice and evidence of compensation for those damages.

Bill Text and History

None
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 766
Assembly Bill 766
relating to: recovery of noneconomic damages in medical malpractice cases.

Bill Text and History

None
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 844
Assembly Bill 844
relating to: the Health Insurance Risk-Sharing Plan; creating the Health Insurance Risk-Sharing Plan Authority; a health benefit program for persons eligible for tax credits for payment of premiums; an income and franchise tax credit for Health Insurance R...

Bill Text and History

2005 Wisconsin Act 74

None
Notification Date
11/29/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 1067
Assembly Bill 1067
relating to: regulating payments and gifts by drug manufacturers and distributors and consulting agreements between certain health care providers and drug manufacturers and distributors and providing a penalty.

Bill Text and History

Against
Notification Date
3/9/2006
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 58
Senate Bill 58
relating to: product liability of manufacturers, distributors, and sellers.

Bill Text and History

None
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 78
Senate Bill 78
relating to: pseudoephedrine hydrochloride and other materials used to produce methamphetamine, the distribution of methamphetamine to minors, and providing penalties.

Bill Text and History

2005 Wisconsin Act 14

None
Notification Date
4/14/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 212
Senate Bill 212
relating to: advertising for prescription drugs.

Bill Text and History

Against
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 402
Senate Bill 402
relating to: actions against manufacturers, distributors, sellers, and promoters of products.

Bill Text and History

None
Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health and Family Services: Medical Assistance
Biennial budget bill treatment of matter relating to
Health and Family Services: Medical Assistance

Notification Date
2/14/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
Medicaid budget: Access to pharmaceuticals; MA spending and revenues

Health and Family Services: Prescription Drug Assistance
Biennial budget bill treatment of matter relating to
Health and Family Services: Prescription Drug Assistance

Notification Date
2/14/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
Pharmaceutical expenditures in the Medicaid, BadgerCare and SeniorCare programs

Topics Not Yet Assigned A Bill Or Rule Number

DHFS Pharmacy Reimbursement Commission
Development, drafting or introduction of a proposal relating to
DHFS Pharmacy Reimbursement Commission

Action Intended To Affect
Legislative Matter

Notification Date
12/6/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

ensuring access of Wisconsin citizens to drugs which treat mental illness
Development, drafting or introduction of a proposal relating to
ensuring access of Wisconsin citizens to drugs which treat mental illness

Action Intended To Affect
Legislative Matter

Notification Date
1/25/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

restrictions in the sale of products containing pseudoephedrine
Development, drafting or introduction of a proposal relating to
restrictions in the sale of products containing pseudoephedrine

Action Intended To Affect
Legislative Matter

Notification Date
1/25/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

creating and administering a preferred drug list for Medicaid, Badgercare and SeniorCare
Development, drafting or introduction of a proposal relating to
creating and administering a preferred drug list for Medicaid, Badgercare and SeniorCare

Action Intended To Affect
Legislative Matter

Notification Date
1/5/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

funding and administration of the HIRSP program
Development, drafting or introduction of a proposal relating to
funding and administration of the HIRSP program

Action Intended To Affect
Legislative Matter

Notification Date
1/5/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Regulation of pharmaceutical manufacturer's marketing practices
Development, drafting or introduction of a proposal relating to
Regulation of pharmaceutical manufacturer's marketing practices

Action Intended To Affect
Legislative Matter

Notification Date
1/5/2005
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
Total Lobbying Expenditures 2005
January - June
$37,849.97
2005
July - December
$34,546.42
2006
January - June
$35,137.67
2006
July - December
$26,632.49
Total $134,166.56
Total Hours Communicating 2005
January - June
77.50
2005
July - December
42.50
2006
January - June
40.00
2006
July - December
34.50
Total 194.50
Total Hours Other 2005
January - June
235.00
2005
July - December
180.00
2006
January - June
139.00
2006
July - December
187.50
Total 741.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

relating to: pseudoephedrine hydrochloride and other materials used to produce methamphetamine, the distribution of methamphetamine to minors, and providing penalties.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
35%
2005
July - December
2006
January - June
2006
July - December
Total 12%
relating to: gifts given or offered by prescription drug manufacturers and distributors to encourage practitioners to prescribe certain drugs and providing a penalty.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
10%
2006
January - June
20%
2006
July - December
Total 6%
relating to: product liability of manufacturers, distributors, and sellers.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
5%
2006
July - December
Total < 1%
relating to: an income and franchise tax credit for sales and use taxes paid on the purchase of electricity used in agricultural biotechnology and on the purchase of products used on livestock.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
5%
2006
July - December
Total < 1%
relating to: awards to persons suffering damages as the result of medical malpractice and evidence of compensation for those damages.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
5%
2006
July - December
Total < 1%
relating to: recovery of noneconomic damages in medical malpractice cases.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
5%
2006
July - December
Total < 1%
relating to: advertising for prescription drugs.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
10%
2006
July - December
Total 2%
relating to: advertising for prescription drugs.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
10%
2006
July - December
Total 2%
relating to: the Health Insurance Risk-Sharing Plan; creating the Health Insurance Risk-Sharing Plan Authority; a health benefit program for persons eligible for tax credits for payment of premiums; an income and franchise tax credit for Health Insurance Risk-Sharing Plan assessments; and making an appropriation.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
10%
2006
July - December
Total 2%
relating to: regulating payments and gifts by drug manufacturers and distributors and consulting agreements between certain health care providers and drug manufacturers and distributors and providing a penalty.
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
20%
2006
July - December
Total 4%

Budget Bill Subjects

2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
25%
2005
July - December
10%
2006
January - June
2006
July - December
Total 11%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
20%
2005
July - December
2006
January - June
2006
July - December
Total 7%
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
15%
2006
January - June
2006
July - December
Total 4%
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
35%
2006
January - June
2006
July - December
15%
Total 12%
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
10%
2006
July - December
Total 2%
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
2006
July - December
10%
Total 2%
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
2005
July - December
2006
January - June
2006
July - December
10%
Total 2%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
15%
2005
July - December
10%
2006
January - June
2006
July - December
5%
Total 9%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2005
January - June
2005
July - December
2006
January - June
2006
July - December
Total
2005
January - June
5%
2005
July - December
20%
2006
January - June
2006
July - December
60%
Total 21%

Filed Statements of Lobbying Activity and Expenditures